HAEK — Haemato AG Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- €53.68m
- €30.71m
- €248.14m
Annual cashflow statement for Haemato AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6.28 | -1.17 | -4.83 | 6.53 | 8.19 |
| Depreciation | |||||
| Non-Cash Items | -0.266 | 2.15 | 7.2 | 4.41 | -0.37 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.91 | -5.66 | 10.6 | -1.3 | 10.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.558 | -2.76 | 14.7 | 11.1 | 19.7 |
| Capital Expenditures | -1.07 | -1.09 | -0.854 | -0.327 | -1.09 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 7.28 | 0.391 | 0.01 | 0.155 | -1.52 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.21 | -0.701 | -0.844 | -0.172 | -2.61 |
| Financing Cash Flow Items | -1.08 | -0.714 | -0.777 | -0.396 | -0.32 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -7.64 | 0.049 | -4.49 | 7.16 | -18.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.87 | -3.42 | 9.33 | 18.1 | -1.79 |